trial

Energetics and Glutamate in Schizophrenia

NCTId NCT06236048
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Recruiting
Enrollment 75 (estimated)
Sponsored by King's College London
Primary completion 2027-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
75 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2024-03-04
Primary completion
2027-12-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
MRI scanPET-MR scan

Sponsors

King's College LondonLead Sponsor

Sites

1 total
London, United Kingdom

Facts & assertions

4 sourced
Enrollment
75
Phase
NA
Primary Completion Date
2027-12-31
Status
RECRUITING
relationships
The graph out of here
drug
MRI scan
drug
PET-MR scan
drug
lead_sponsor
King's College London
company
indication
Schizophrenia
indication
Schizophrenia
indication